THE MCMANUS GROUP for ALLERGAN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B drugs payments and access. S. 551, the REFUND Act, S. 2543, the Prescription Drug Pricing Reduction Act, and H.R. 3, the Lower Drug Costs Now Act.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Copyright/Patent/Trademark CPT
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA HOCHUL | — |
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.